- Home
- KINS vs LUCD Comparison
KINS vs LUCD Comparison
Compare KINS & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KINS | LUCD |
|---|---|---|
| Founded | 1886 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.7M | 182.2M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KINS | LUCD |
|---|---|---|
| Price | $15.83 | $1.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 127.2K | ★ 893.8K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 94.59 | 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $214,867,301.00 | $4,346,000.00 |
| Revenue This Year | $24.23 | $115.58 |
| Revenue Next Year | $18.05 | $130.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 38.50 | ★ 79.00 |
| 52 Week Low | $13.08 | $0.90 |
| 52 Week High | $19.42 | $1.70 |
Technical Indicators
Market Signals| Indicator | KINS | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 50.29 |
| Support Level | $15.64 | $1.02 |
| Resistance Level | $17.28 | $1.12 |
| Average True Range (ATR) | 0.75 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 72.57 | 79.62 |
Price Performance
Historical ComparisonAbout KINS Kingstone Companies Inc.
Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.